Acetylation of PPARγ in macrophages promotes visceral fat degeneration in obesity

Abstract

Obesity is characterized by chronic, low-grade inflammation, which is driven by macrophage infiltration of adipose tissue. PPARγ is well established to have an anti-inflammatory function in macrophages, but the mechanism that regulates its function in these cells remains to be fully elucidated. PPARγ undergoes post-translational modifications (PTMs), including acetylation, to mediate ligand responses, including on metabolic functions. Here, we report that PPARγ acetylation in macrophages promotes their infiltration into adipose tissue, exacerbating metabolic dysregulation. We generated a mouse line that expresses a macrophage-specific, constitutive acetylation-mimetic form of PPARγ (K293Q^flox/flox:LysM-cre, mK293Q) to dissect the role of PPARγ acetylation in macrophages. Upon high-fat diet feeding to stimulate macrophage infiltration into adipose tissue, we assessed the overall metabolic profile and tissue-specific phenotype of the mutant mice, including responses to the PPARγ agonist Rosiglitazone. Macrophage-specific PPARγ K293Q expression promotes proinflammatory macrophage infiltration and fibrosis in epididymal white adipose tissue, but not in subcutaneous or brown adipose tissue, leading to decreased energy expenditure, insulin sensitivity, glucose tolerance, and adipose tissue function. Furthermore, mK293Q mice are resistant to Rosiglitazone-induced improvements in adipose tissue remodeling. Our study reveals that acetylation is a new layer of PPARγ regulation in macrophage activation, and highlights the importance and potential therapeutic implications of such PTMs in regulating metabolism.

Keywords

PPARγ acetylation / adipose tissue remodeling / macrophage / inflammation / fibrosis

References

[1] Hotamisligil GS, Murray DL, Choy LN et al. Tumor necrosis factor alpha inhibits signaling from the insulin receptor Proc Natl Acad Sci USA 1994; 91: 4854- 8.

[2] Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes J Clin Invest 2005; 115: 1111- 9.

[3] Weisberg SP, McCann D, Desai M et al. Obesity is associated with macrophage accumulation in adipose tissue J Clin Invest 2003; 112: 1796- 808.

[4] Xu H, Barnes GT, Yang Q et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J Clin Invest 2003; 112: 1821- 30.

[5] Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 1993; 259: 87- 91.

[6] Patsouris D, Li PP, Thapar D et al. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals Cell Metab 2008; 8: 301- 9.

[7] Aouadi M, Tencerova M, Vangala P et al. Gene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice Proc Natl Acad Sci USA 2013; 110: 8278- 83.

[8] Aouadi M, Vangala P, Yawe JC et al. Lipid storage by adipose tissue macrophages regulates systemic glucose tolerance Am J Physiol Endocrinol Metab 2014; 307: E374- 83.

[9] Rosen ED, Sarraf P, Troy AE et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro Mol Cell 1999; 4: 611- 7.

[10] Koutnikova H, Cock TA, Watanabe M et al. Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice Proc Natl Acad Sci USA 2003; 100: 14457- 62.

[11] Ricote M, Li AC, Willson TM et al. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation Nature 1998; 391: 79- 82.

[12] Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor Cell 1994; 79: 1147- 56.

[13] Jiang C, Ting AT, Seed B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines Nature 1998; 391: 82- 6.

[14] Stienstra R, Duval C, Keshtkar S et al. Peroxisome proliferator-activated receptor γ activation promotes infiltration of alternatively activated macrophages into adipose tissue J Biol Chem 2008; 283: 22620- 7.

[15] Huang JT, Welch JS, Ricote M et al. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase Nature 1999; 400: 378- 82.

[16] Odegaard JI, Ricardo-Gonzalez RR, Goforth MH et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance Nature 2007; 447: 1116- 20.

[17] Bouhlel MA, Derudas B, Rigamonti E et al. PPARγ activation primes human monocytes into alternative m2 macrophages with anti-inflammatory properties Cell Metab 2007; 6: 137- 43.

[18] Qiang L, Wang L, Kon N et al. Brown remodeling of white adipose tissue by SIRT1-dependent deacetylation of PPARγ Cell 2012; 150: 620- 32.

[19] Kraakman MJ, Liu Q, Postigo-Fernandez J et al. PPARγ deacetylation dissociates thiazolidinedione’s metabolic benefits from its adverse effects J Clin Invest 2018; 128: 2600- 12.

[20] Weisberg SP, Hunter D, Huber R et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding J Clin Invest 2006; 116: 115- 24.

[21] Bruun JM, Lihn AS, Pedersen SB et al. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT J Clin Endocrinol Metab 2005; 90: 2282- 9.

[22] Okamoto Y, Higashiyama H, Rong JX et al. Comparison of mitochondrial and macrophage content between subcutaneous and visceral fat in db/db mice Exp Mol Pathol 2007; 83: 73- 83.

[23] Curat CA, Wegner V, Sengenès C et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin Diabetologia 2006; 49: 744- 7.

[24] Bodles AM, Varma V, Yao-Borengasser A et al. Pioglitazone induces apoptosis of macrophages in human adipose tissue J Lipid Res 2006; 47: 2080- 8.

[25] Amano SU, Cohen JL, Vangala P et al. Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation Cell Metab 2014; 19: 162- 71.

[26] Kamei N, Tobe K, Suzuki R et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance J Biol Chem 2006; 281: 26602- 14.

[27] Kanda H, Tateya S, Tamori Y et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity J Clin Invest 2006; 116: 1494- 505.

[28] Wang Y, Li N, Zhang X et al. Mitochondrial metabolism regulates macrophage biology J Biol Chem 2021; 297: 100904.

[29] de Toro-Martín J, Guénard F, Tchernof A et al. Methylation quantitative trait loci within the TOMM20 gene are associated with metabolic syndrome-related lipid alterations in severely obese subjects Diabetol Metab Syndr 2016; 8: 55.

[30] Jung S-B, Choi MJ, Ryu D et al. Reduced oxidative capacity in macrophages results in systemic insulin resistance Nat Commun 2018; 9: 1551.

[31] Soro-Arnaiz I, Li QOY, Torres-Capelli M et al. Role of mitochondrial complex IV in age-dependent obesity Cell Rep 2016; 16: 2991- 3002.

[32] Lo JC, Ljubicic S, Leibiger B et al. Adipsin is an adipokine that improves β cell function in diabetes Cell 2014; 158: 41- 53.

[33] Debari MK, Abbott RD. Adipose tissue fibrosis: mechanisms, models, and importance Mol Sci 2020; 21: 6030.

[34] Tanaka M, Ikeda K, Suganami T et al. Macrophage-inducible C-type lectin underlies obesity-induced adipose tissue fibrosis Nat Commun 2014; 5: 4982.

[35] Spencer M, Yao-Borengasser A, Unal R et al. Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation Am J Physiol Endocrinol Metab 2010; 299: E1016- 27.

[36] Orlicky DJ, Libby AE, Bales ES et al. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions J Physiol 2019; 597: 1565- 84.

[37] Obradovic M, Sudar-Milovanovic E, Soskic S et al. Leptin and obesity: role and clinical implication Front Endocrinol (Lausanne) 2021; 12: 585887.

[38] Nuwormegbe SA, Sohn JH, Kim SW. A PPAR-gamma agonist rosiglitazone suppresses fibrotic response in human pterygium fibroblasts by modulating the p38 MAPK pathway Investig Ophthalmol Vis Sci 2017; 58: 5217- 26.

[39] Viola A, Munari F, Sánchez-Rodríguez R et al. The metabolic signature of macrophage responses Front Immunol 2019; 10: 1462.

[40] Pascual G, Fong AL, Ogawa S et al. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPARγ Nature 2005; 437: 759- 63.

[41] Ohashi K, Parker JL, Ouchi N et al. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype J Biol Chem 2010; 285: 6153- 60.

[42] Hui X, Gu P, Zhang J et al. Adiponectin enhances cold-induced browning of subcutaneous adipose tissue via promoting M2 macrophage proliferation Cell Metab 2015; 22: 279- 90.

[43] Ajuwon KM, Spurlock ME. Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes Am J Physiol Regul Integr Comp Physiol 2005; 288: R1220- 5.

[44] Flier JS, Cook KS, Usher P et al. Severely impaired adipsin expression in genetic and acquired obesity Science 1987; 237: 405- 8.

[45] Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors Endocr Rev 2005; 26: 439- 51.

[46] Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARγ Annu Rev Biochem 2008; 77: 289- 312.

[47] He W, Barak Y, Hevener A et al. Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle Proc Natl Acad Sci USA 2003; 100: 15712- 7.

[48] Takahashi H, Alves CRR, Stanford KI et al. TGF-β2 is an exercise-induced adipokine that regulates glucose and fatty acid metabolism Nat Metab 2019; 1: 291- 303.

[49] Vetuschi A, Pompili S, Gaudio E et al. PPAR-γ with its anti-inflammatory and anti-fibrotic action could be an effective therapeutic target in IBD Eur Rev Med Pharmacol Sci 2018; 22: 8839- 48.

[50] Zhang X, Goncalves R, Mosser DM. The isolation and characterization of murine macrophages Curr Protoc Immunol 2008 ;Chapter 14:Unit 14.1.

RIGHTS & PERMISSIONS

2022 The Author(s) 2022. Published by Oxford University Press on behalf of Higher Education Press.